SCHEMBL21512942

SCHEMBL21512942

CCN1C(=O)C2(CCC2)c2c1cnc1ccc(-c3cnc(OCCNC)c(C)c3)cc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 7/20 0.48
▸ PRKDC P78527 4/20 0.48
▸ CDC7 O00311 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ HIPK2 Q9H2X6 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ MTOR P42345 5/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 6/20 0.34
▸ ATR Q13535 4/20 0.34
▸ TLR7 Q9NYK1 1/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ TLR8 Q9NR97 1/20 0.31
▸ GRK2 P25098 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL26133023 0.88 PRKDC (0.57) ATMPRKDCMTORPIK3CDPIK3CA
Hydrochloric Acid SCHEMBL29969815 0.88 PRKDC (0.57) ATMPRKDCMTORPIK3CDPIK3CA
SCHEMBL29969176 0.87 ATM (0.45) ATMPRKDCMTORPIK3CAATR
SCHEMBL29968770 0.78 PRKDC (0.69) ATMPRKDCMTORPIK3CDPIK3CA
SCHEMBL21512956 0.78 PRKDC (0.69) ATMPRKDCMTORPIK3CDPIK3CA
SCHEMBL29968617 0.77 ATM (0.53) ATMPRKDCMTORPIK3CAATR
SCHEMBL21512943 0.76 PRKDC (0.70) ATMPRKDCMTORPIK3CDPIK3CA
SCHEMBL30613758 0.76 PRKDC (0.70) ATMPRKDCMTORPIK3CDPIK3CA
SCHEMBL21512618 0.75 PRKDC (0.64) ATMPRKDCMTORPIK3CDPIK3CA
SCHEMBL29970246 0.75 PRKDC (0.64) ATMPRKDCMTORPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019201283-A1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS, INC. (US) 2019-10-24 — — WO disclosed
Send feedback